Cardiovascular Systems, Inc. (CSII)

34.16
NASDAQ
Prev Close 34.16
Day Low/High 0.00 / 0.00
52 Wk Low/High 21.88 / 42.64
Exchange NASDAQ
Shares Outstanding 34.82B
Market Cap 1.19B
Div & Yield N.A. (N.A)
Cardiovascular Systems Announces Plans For New Corporate Headquarters

Cardiovascular Systems Announces Plans For New Corporate Headquarters

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), today announced plans to build a new corporate headquarters in New Brighton, Minn.

Cardiovascular Systems Enrolls First Patient In Coast Study

Cardiovascular Systems Enrolls First Patient In Coast Study

Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII), announced that the first patient has been enrolled in its Coronary Orbital Atherectomy System Trial (COAST) trial.

CSII Makes Bullish Cross Above Critical Moving Average

CSII Makes Bullish Cross Above Critical Moving Average

In trading on Wednesday, shares of Cardiovascular Systems, Inc crossed above their 200 day moving average of $28.71, changing hands as high as $28.94 per share. Cardiovascular Systems, Inc shares are currently trading up about 2.2% on the day.

Cardiovascular Systems Announces Coronary Data At Late-Breaker SCAI 2014 Scientific Sessions

Cardiovascular Systems Announces Coronary Data At Late-Breaker SCAI 2014 Scientific Sessions

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), presented one-year data and a new economic analysis from its ORBIT II coronary study in a late-breaker session at the Society for Cardiovascular Angiography and ...

Cardiovascular Systems Coronary Data Highlighted In Late-Breaking Presentation At EuroPCR Conference

Cardiovascular Systems Coronary Data Highlighted In Late-Breaking Presentation At EuroPCR Conference

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), announced new one-year data and an economic analysis from its ORBIT II coronary study in a late-breaking presentation at the 2014 European Association of Percutaneous...

Cardiovascular Systems To Feature Late-Breaking Coronary Data At SCAI 2014 Scientific Sessions

Cardiovascular Systems To Feature Late-Breaking Coronary Data At SCAI 2014 Scientific Sessions

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), will feature one-year data and an economic analysis from its ORBIT II coronary study in a late-breaking presentation at the Society for Cardiovascular Angiography and...

Cardiovascular Systems is Now Oversold (CSII)

Cardiovascular Systems is Now Oversold (CSII)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Cardiovascular Systems (CSII) Marked As A Dead Cat Bounce Stock

Cardiovascular Systems (CSII) Marked As A Dead Cat Bounce Stock

Trade-Ideas LLC identified Cardiovascular Systems (CSII) as a "dead cat bounce" (down big yesterday but up big today) candidate

Notable Two Hundred Day Moving Average Cross - CSII

Notable Two Hundred Day Moving Average Cross - CSII

In trading on Friday, shares of Cardiovascular Systems, Inc crossed below their 200 day moving average of $28.18, changing hands as low as $28.11 per share. Cardiovascular Systems, Inc shares are currently trading off about 2.5% on the day.

Insider Trading Alert - SM, KEX And CSII Traded By Insiders

Insider Trading Alert - SM, KEX And CSII Traded By Insiders

Stocks with insider trader activity include SM, KEX and CSII

Cardiovascular Systems Reports Fiscal 2014 Third-Quarter Financial Results

Cardiovascular Systems Reports Fiscal 2014 Third-Quarter Financial Results

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for peripheral and coronary artery disease, today reported...

Insider Trading Alert - CSII, PAG And CCE Traded By Insiders

Insider Trading Alert - CSII, PAG And CCE Traded By Insiders

Stocks with insider trader activity include CSII, PAG and CCE

Cardiovascular Systems To Webcast Fiscal 2014 Third-Quarter Earnings Conference Call Wednesday, April 30

Cardiovascular Systems To Webcast Fiscal 2014 Third-Quarter Earnings Conference Call Wednesday, April 30

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) will host a live webcast of its fiscal 2014 third-quarter conference call on Wednesday, April 30, 2014, at 3:45 p.

Notable Two Hundred Day Moving Average Cross - CSII

Notable Two Hundred Day Moving Average Cross - CSII

In trading on Thursday, shares of Cardiovascular Systems, Inc crossed below their 200 day moving average of $27.54, changing hands as low as $27.12 per share. Cardiovascular Systems, Inc shares are currently trading down about 4.9% on the day.

Cardiovascular Systems Becomes Oversold (CSII)

Cardiovascular Systems Becomes Oversold (CSII)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Use Options For a Chance To Buy CSII at a 28% Discount

Use Options For a Chance To Buy CSII at a 28% Discount

Looking back to 133 days ago, Cardiovascular Systems, Inc priced a 2,608,696 share secondary stock offering at $30 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time and based on early trading on Wednesday, the stock is now 7.8% higher than the offering price.

Cardiovascular Systems Presenting ORBIT II Study One-Year Coronary Data During 2014 American College Of Cardiology Conference

Cardiovascular Systems Presenting ORBIT II Study One-Year Coronary Data During 2014 American College Of Cardiology Conference

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), will feature one-year data from the ORBIT II study of the company’s Diamondback 360 ® Coronary Orbital Atherectomy System.

Cardiovascular Systems' New 60cm Diamondback 360(R) Peripheral Orbital Atherectomy System Was Recently Cleared By The U.S. Food And Drug Administration To Treat Peripheral Arterial Disease (PAD). (Photo: Business Wire)

Cardiovascular Systems' New 60cm Diamondback 360(R) Peripheral Orbital Atherectomy System Was Recently Cleared By The U.S. Food And Drug Administration To Treat Peripheral Arterial Disease (PAD). (Photo: Business Wire)

Cardiovascular Systems, Inc. (NASDAQ: CSII) (CSI), today announced the first use of its Diamondback 360 ® 60cm Peripheral Orbital Atherectomy Systems (OAS) for the treatment of peripheral arterial disease (PAD).

Cardiovascular Systems Receives FDA Clearance For Low Profile, 60cm Diamondback Devices Designed To Expand The Treatment Of Peripheral Artery Disease (PAD)

Cardiovascular Systems Receives FDA Clearance For Low Profile, 60cm Diamondback Devices Designed To Expand The Treatment Of Peripheral Artery Disease (PAD)

Cardiovascular Systems, Inc. (NASDAQ: CSII) (CSI), announced today it has received FDA clearance of its new Diamondback 360 ® 60cm Peripheral Orbital Atherectomy Systems (OAS) for the treatment of peripheral...

Cardiovascular Systems Releases One-Year Orbit II Coronary Data At 2014 Cardiovascular Research Technologies Conference

Cardiovascular Systems Releases One-Year Orbit II Coronary Data At 2014 Cardiovascular Research Technologies Conference

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), released one-year data from its ORBIT II study of the company’s Diamondback 360 ® Coronary Orbital Atherectomy System in treating severely calcified lesions...

Cardiovascular Systems To Present ORBIT II Coronary Data At 2014 Cardiovascular Research Technologies Conference

Cardiovascular Systems To Present ORBIT II Coronary Data At 2014 Cardiovascular Research Technologies Conference

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), will release one-year data from the ORBIT II study of the company’s Diamondback 360 ® Coronary Orbital Atherectomy System in treating severely calcified ...

Use Options For a Chance To Buy CSII at a 32% Discount

Use Options For a Chance To Buy CSII at a 32% Discount

Looking back to 75 days ago, Cardiovascular Systems priced a 2,608,696 share secondary stock offering at $30 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time and based on early trading on Monday, the stock is now 12.3% above the offering price.

Cardiovascular Systems Reports Fiscal 2014 Second-Quarter Financial Results

Cardiovascular Systems Reports Fiscal 2014 Second-Quarter Financial Results

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for vascular and coronary disease, today reported financial results...

Physician Demand Continues To Build For Cardiovascular Systems’ New Coronary Artery Disease Treatment Technology

Physician Demand Continues To Build For Cardiovascular Systems’ New Coronary Artery Disease Treatment Technology

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), today announced that physician demand continues to build throughout the United States for its recently approved Diamondback 360 ® Coronary Orbital Atherectomy...

Cardiovascular Systems To Webcast Fiscal 2014 Second-Quarter Earnings Conference Call Wednesday, January 29

Cardiovascular Systems To Webcast Fiscal 2014 Second-Quarter Earnings Conference Call Wednesday, January 29

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) will host a live webcast of its fiscal 2014 second-quarter conference call on Wednesday, Jan.

Cardiovascular Systems Becomes Oversold (CSII)

Cardiovascular Systems Becomes Oversold (CSII)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Physicians Throughout U.S. Using Cardiovascular Systems’ New Technology To Treat Coronary Artery Disease

Physicians Throughout U.S. Using Cardiovascular Systems’ New Technology To Treat Coronary Artery Disease

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), today announced that its new Diamondback 360 ® Coronary Orbital Atherectomy System (OAS) is being used by physicians across the country to treat coronary artery...

Cardiovascular Systems Announces Closing Of Common Stock Offering And Full Exercise Of Underwriters’ Option To Purchase Additional Shares

Cardiovascular Systems Announces Closing Of Common Stock Offering And Full Exercise Of Underwriters’ Option To Purchase Additional Shares

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII) today announced the closing of its underwritten registered public offering of an aggregate of 3,000,000 shares of its common stock, including 391,304 shares of common...

Cardiovascular Systems Prices Public Offering Of Common Stock

Cardiovascular Systems Prices Public Offering Of Common Stock

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), a medical device company focused on developing and commercializing innovative interventional treatment systems for vascular disease, today announced the pricing of an...

Cardiovascular Systems Announces Proposed Public Offering Of Common Stock

Cardiovascular Systems Announces Proposed Public Offering Of Common Stock

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), a medical device company focused on developing and commercializing innovative interventional treatment systems for vascular disease, today announced that it intends to...

TheStreet Quant Rating: C (Hold)